SEC Filings
Form 4 |
FIBROGEN INC filed this Form 4 on 12/06/2018 |
Document Outline |
Entire Document (4.8 KB) |
Subdocument 1 - 4 - FORM 4 SUBMISSION |
Investors And Media
FibroGen Inc.
NASDAQ: FGEN
$58.50
1.54 (2.70%)Volume: 531,39402/15/19 4:00 p.m. ET Data provided by Nasdaq. Minimum 15 minutes delayed.Investor and Media Contact
-
Karen L. Bergman
Vice President, Investor Relations and Corporate Communications
+1 (415) 978 - 1200
ir@fibrogen.com